Works matching DE "LYMPHOBLASTIC leukemia treatment"

Results: 900
    1
    2
    3
    4
    5
    6
    7

    Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.

    Published in:
    2022
    By:
    • Garcia-Prieto, Carlos A;
    • Villanueva, Lorea;
    • Bueno-Costa, Alberto;
    • Davalos, Veronica;
    • González-Navarro, Europa Azucena;
    • Juan, Manel;
    • Urbano-Ispizua, Álvaro;
    • Delgado, Julio;
    • Ortiz-Maldonado, Valentín;
    • Bufalo, Francesca del;
    • Locatelli, Franco;
    • Quintarelli, Concetta;
    • Sinibaldi, Matilde;
    • Soler, Marta;
    • Moura, Manuel Castro de;
    • Ferrer, Gerardo;
    • Urdinguio, Rocio G;
    • Fernandez, Agustin F;
    • Fraga, Mario F;
    • Bar, Diana
    Publication type:
    Journal Article
    8

    Use of Appropriate Initial Treatment Among Adolescents and Young Adults With Cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 11, p. 1, doi. 10.1093/jnci/dju300
    By:
    • Potosky, Arnold L.;
    • Harlan, Linda C.;
    • Albritton, Karen;
    • Cress, Rosemary D.;
    • Friedman, Debra L.;
    • Hamilton, Ann S.;
    • Kato, Ikuko;
    • Keegan, Theresa H. M.;
    • Keel, Gretchen;
    • Schwartz, Stephen M.;
    • Seibel, Nita L.;
    • Shnorhavorian, Margarett;
    • West, Michele M.;
    • Xiao-Cheng Wu
    Publication type:
    Article
    9
    10

    CASE REPORT.

    Published in:
    2018
    By:
    • Basile, Patrick;
    • Falk, Nathan
    Publication type:
    Case Study
    11
    12
    13

    Long‐term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis.

    Published in:
    Internal Medicine Journal, 2023, v. 53, n. 11, p. 1979, doi. 10.1111/imj.16043
    By:
    • Blennerhassett, Richard;
    • Othman, Jad;
    • Biscoe, Amber;
    • Kliman, David;
    • Mills, Georgia;
    • Blyth, Emily;
    • Micklethwaite, Kenneth;
    • Kwan, John;
    • Bilmon, Ian;
    • Bhattacharyya, Abir;
    • Panicker, Shyam;
    • Fay, Keith;
    • Milliken, Sam;
    • Ma, David;
    • Hamad, Nada;
    • Stevenson, William;
    • Arthur, Chris;
    • Moore, John;
    • Greenwood, Matthew;
    • Gottlieb, David
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL.

    Published in:
    Leukemia (08876924), 2013, v. 27, n. 2, p. 370, doi. 10.1038/leu.2012.234
    By:
    • Garand, R;
    • Beldjord, K;
    • Cavé, H;
    • Fossat, C;
    • Arnoux, I;
    • Asnafi, V;
    • Bertrand, Y;
    • Boulland, M-L;
    • Brouzes, C;
    • Clappier, E;
    • Delabesse, E;
    • Fest, T;
    • Garnache-Ottou, F;
    • Huguet, F;
    • Jacob, M-C;
    • Kuhlein, E;
    • Marty-Grès, S;
    • Plesa, A;
    • Robillard, N;
    • Roussel, M
    Publication type:
    Article
    40
    41

    Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia.

    Published in:
    Leukemia (08876924), 2012, v. 26, n. 7, p. 1517, doi. 10.1038/leu.2012.31
    By:
    • Vilas-Zornoza, A;
    • Agirre, X;
    • Abizanda, G;
    • Moreno, C;
    • Segura, V;
    • De Martino Rodriguez, A;
    • José-Eneriz, E S;
    • Miranda, E;
    • Martín-Subero, J I;
    • Garate, L;
    • Blanco-Prieto, M J;
    • García de Jalón, J A;
    • Rio, P;
    • Rifón, J;
    • Cigudosa, J C;
    • Martinez-Climent, J A;
    • Román-Gómez, J;
    • Calasanz, M J;
    • Ribera, J M;
    • Prósper, F
    Publication type:
    Article
    42
    43

    Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON.

    Published in:
    Leukemia (08876924), 2012, v. 26, n. 7, p. 1726, doi. 10.1038/leu.2012.53
    By:
    • Daenen, S;
    • van der Holt, B;
    • Dekker, A W;
    • Willemze, R;
    • Rijneveld, A W;
    • Biemond, B J;
    • Muus, P;
    • van de Loosdrecht, A A;
    • Schouten, H C;
    • van Marwijk Kooy, M;
    • Breems, D A;
    • Demuynck, H;
    • Maertens, J;
    • Wijermans, P W;
    • Wittebol, S;
    • de Klerk, E W;
    • Cornelissen, J J
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50